Rankings
▼
Calendar
XERS Q2 2017 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena
XERS
Xeris Biopharma Holdings, Inc.
$982M
Q2 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$565,000
Gross Profit
$561,000
99.3% margin
Operating Income
-$5M
-920.2% margin
Net Income
-$5M
-926.0% margin
EPS (Diluted)
$-2.59
QoQ Revenue Growth
+59.6%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$89,000
← FY 2017
All Quarters
Q3 2017 →
